1 completed, 1 terminated, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow COVI-DROPS: new trials by email Literature Review of COVI-DROPS trials Research Report on COVI-DROPS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US) COVI-DROPS, Placebo - Covid19 | Phase 2 | Completed | Sorrento Therapeutics, Inc. | 97 | 2021-11-16 | 2022-02-03 |
| Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection COVI-DROPS, Placebo - COVID-19 | Phase 2 | Withdrawn | Sorrento Therapeutics, Inc. | 2021-11-01 | 2022-02-03 | |
| Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK) COVI-DROPS, Placebo - Covid19 | Phase 2 | Terminated | Sorrento Therapeutics, Inc. | 179 | 2021-07-16 | 2023-01-30 |
COVID-19 (3)
Sorrento Therapeutics, Inc. (3)
United Kingdom (1) · United States (1)
Mike Royal, MD (3)